Literature DB >> 445959

Kinetics of intravenous amoxicillin in patients on long-term dialysis.

E L Francke, G B Appel, H C Neu.   

Abstract

The kinetics of intravenous amoxicillin was studied in 8 patients with creatinine clearances of less than 7 ml/min who were on long-term hemodialysis. Kinetic parameters were determined using a 2-compartment linear model. The serum half-life (t1/2) of amoxicillin in these patients ranged from 7.5 to 21 hr. The t1/2 fell to 2.84 +/- 0.45 hr during dialysis. Approximately 30% of the dose was recovered in the dialysate during 4 hr of dialysis and there was a 25% reduction per hour in serum concentration. We present a dosage schedule for intravenous amoxicillin in patients with reduced renal function who are undergoing hemodialysis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 445959     DOI: 10.1002/cpt197926131

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of Augmentin.

Authors:  B E Davies; R Boon; R Horton; F C Reubi; C E Descoeudres
Journal:  Br J Clin Pharmacol       Date:  1988-10       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

3.  Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Authors:  Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

Review 4.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 5.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

Review 6.  Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis.

Authors:  Mitsushige Sugimoto; Hideo Yasuda; Akira Andoh
Journal:  World J Gastroenterol       Date:  2018-04-21       Impact factor: 5.742

7.  In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model.

Authors:  M G Vossen; S Pferschy; C Milacek; M Haidinger; Mario Karolyi; Zoltan Vass; Heinz Burgmann; Alexandra Maier-Salamon; S G Wicha; W Jäger; M Zeitlinger; T Stimpfl; T Wittek; F Thalhammer
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.